Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations

v3.23.3
Condensed Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Condensed Statements of Operations        
Revenue - related party $ 31 $ 48 $ 97 $ 118
Operating expenses:        
Research and development 5,496 8,866 35,267 35,589
General and administrative 2,236 1,846 6,809 6,218
Total operating expenses 7,732 10,712 42,076 41,807
Loss from operations (7,701) (10,664) (41,979) (41,689)
Other income        
Interest income 7 52 81 87
Gain on common stock warrant liabilities 1,970   9,179  
Total other income 1,977 52 9,260 87
Net Loss $ (5,724) $ (10,612) $ (32,719) $ (41,602)
Loss per Share:        
Basic net loss per common share outstanding $ (0.29) $ (1.20) $ (2.07) $ (4.78)
Diluted net loss per common share outstanding $ (0.29) $ (1.20) $ (2.07) $ (4.78)
Basic weighted average number of common shares outstanding 19,988,079 8,856,750 15,842,693 8,705,529
Diluted weighted average number of common shares outstanding 19,988,079 8,856,750 15,842,693 8,705,529